Nonpermanent Fillers and Permanent Fillers

  • Murad Alam
  • Nowell Solish


Prepackaged injectable soft-tissue augmentation materials are extremely safe substances [1]. In vivo, they are associated with benign and remitting short-term effects. Medium-term effects are infrequent, and given the nonpermanent nature of the injectables, long-term effects are virtually absent. Interestingly, despite the differences in composition among the various common nonpermanent soft-tissue augmentation materials, they are remarkably similar in the type and frequency of their undesired effects.


Hyaluronic Acid Filler Material Injection Pain Filler Injection Cutaneous Hypersensitivity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Alam M, Gladstone H, Kramer EM, Murphy JP Jr, Nouri K, Neuhaus IM, Spencer JM, Spenceri E, Van Dyke S, Ceilley RI, Lee KK, Menaker G, Monheit GD, Orentreich DS, Raab B, Smith KC, Solish NJ, American Society for Dermatologic Surgery (2008) ASDS guidelines of care: injectable fillers. Dermatol Surg 34 Suppl 1:S115–S148PubMedCrossRefGoogle Scholar
  2. 2.
    Andre P, Lowe NJ, Parc A, Clerici TH, Zimmermann U (2005) Adverse reactions to dermal fillers: a review of European experiences. J Cosmet Laser Ther 7:171–176PubMedCrossRefGoogle Scholar
  3. 3.
    Lowe NJ, Maxwell CA, Patnaik R (2005) Adverse reactions to dermal fillers: review. Dermatol Surg 31:1616–1625PubMedGoogle Scholar
  4. 4.
    Duffy DM (2005) Complications of fillers: overview. Dermatol Surg 31:1626–1633PubMedCrossRefGoogle Scholar
  5. 5.
    Dover JS, Carruthers A, Carruthers J, Alam M (2005) Clinical use of restylane. Skin Therapy Lett 10:5–7PubMedGoogle Scholar
  6. 6.
    Glogau RG, Kane MA (2008) Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg 34(Suppl 1):S105–S109PubMedCrossRefGoogle Scholar
  7. 7.
    Hirsch RJ, Narurkar V, Carruthers J (2006) Management of injected hyaluronic acid induced Tyndall effects. Lasers Surg Med 38:202–204PubMedCrossRefGoogle Scholar
  8. 8.
    Lupton JR, Alster TS (2000) Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg 26:135–137PubMedCrossRefGoogle Scholar
  9. 9.
    Shafir R, Amir A, Gur E (2000) Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg 106:1215–1216PubMedCrossRefGoogle Scholar
  10. 10.
    Fernandez-Acenero MJ, Zamora E, Borbujo J (2003) Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg 29(12):1225–1226PubMedCrossRefGoogle Scholar
  11. 11.
    Raulin C, Greve B, Hartschuh W, Soegding K (2000) Exudative granulomatous reaction to hyaluronic acid (Hylaform). Contact Dermatitis 43:178–179PubMedGoogle Scholar
  12. 12.
    Sidwell RU, Dhillon AP, Butler PE, Rustin MH (2004) Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin Exp Dermatol 29:630–632PubMedCrossRefGoogle Scholar
  13. 13.
    Matarasso SL, Herwick R (2006) Hypersensitivity reaction to nonanimal stabilized hyaluronic acid. J Am Acad Dermatol 55:128–131PubMedCrossRefGoogle Scholar
  14. 14.
    Lowe N, Maxwell CA, Lowe P, Duick MG, Shar K (2001) Hyaluronic acid skin fillers. Adverse reactions and skin testing. J Am Acad Dermatol 45:930–933PubMedCrossRefGoogle Scholar
  15. 15.
    Lerner H (2004) Sculptra-P030050 (presentation to General and Plastic Surgery Devices Advisory Panel). Division of general, restorative and neurological devices, plastic and reconstructive surgical devices, food and drug administrationGoogle Scholar
  16. 16.
    Forbes-McKean K, Handler JA (2004) Sculptra (injectable poly-L-lactic acid) PMA P030050 (presentation to General and Plastic Surgery Devices Advisory Panel). Dermik LaboratoriesGoogle Scholar
  17. 17.
    Collins S, Levin J, Lerner H (2004) FDA panel recommends approval of New-Fill. HIV Treat Bull 5 5(5); p. 21Google Scholar
  18. 18.
    Valantin M-A, Aubron-Olivier C, Ghosn J, Laglenne E, Pauchard M, Schoen H et al (2003) Polylactic acid implants: results of the open-label study VEGA. AIDS 17:2471–2477PubMedCrossRefGoogle Scholar
  19. 19.
    Meszaros L (July 2003) Collagen alternatives for facial soft-tissue augmentation offers good results. Cosmetic Surgery TimesGoogle Scholar
  20. 20.
    Reisberger E-M, Landthaler M, Wiest L, Schroder J, Stolz W (2003) Foreign body granulomas caused by polymethylmethacrylate microspheres. Arch Dermatol 139:17–20PubMedCrossRefGoogle Scholar
  21. 21.
    Cassuto D, Marangoni O, De Santis G, Christensen L (2009) Advanced laser techniques for filler-induced complications. Dermatol Surg 35(Suppl 2):1689–1695PubMedCrossRefGoogle Scholar
  22. 22.
    Soparkar CN, Patrinely JR, Tschen J (2004) Erasing restylane. Ophthal Plast Reconstr Surg 20:317–318PubMedCrossRefGoogle Scholar
  23. 23.
    Lambros V (2004) The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast Reconstr Surg 114:277PubMedCrossRefGoogle Scholar
  24. 24.
    Parada MB, Michalany NS, Hassun KM, Bagatin E, Talarico S (2005) A histologic study of adverse effects of different cosmetic skin fillers. Skinmed 4:345–349PubMedCrossRefGoogle Scholar
  25. 25.
    (2003) CosmoDerm/CosmoPlast collagen replacement therapy (condensed package insert). In: CosmoDerm and CosmoPlast: replacing natural collagen (patient brochure). Inamed Aesthetics, Inamed CorporationGoogle Scholar
  26. 26.
    Bhatia AC, Arndt KA, Dover JS, Kaminer M, Rohrer TE (2005) Bacterial sterility of stored nonanimal stabilized hyaluronic acid-based cutaneous filler. Arch Dermatol 141:1317–1318PubMedCrossRefGoogle Scholar
  27. 27.
    Bellew SG, Carroll KC, Weiss MA, Weiss RA (2005) Sterility of stored nonanimal, stabilized hyaluronic acid gel syringes after patient injection. J Am Acad Dermatol 52:988–990PubMedCrossRefGoogle Scholar
  28. 28.
    Rohrich RJ, Monheit G, Nguyen AT, Brown SA, Fagien S (2010) Soft-tissue filler complications: the important role of biofilms. Plast Reconstr Surg 125:1250–1256PubMedGoogle Scholar
  29. 29.
    Glaich AS, Cohen JL, Goldberg LH (2006) Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg 32:276–281PubMedCrossRefGoogle Scholar
  30. 30.
    Cohen JL, Brown MR (2009) Anatomic considerations for soft tissue augmentation of the face. J Drugs Dermatol 8:13–16PubMedGoogle Scholar
  31. 31.
    Alam M, Levy R, Pavjani U, Ramierez JA, Guitart J, Veen H, Gladstone HB (2006) Safety of radiofrequency treatment over human skin previously injected with medium-term injectable soft-tissue augmentation materials: a controlled pilot trial. Lasers Surg Med 38:205–210PubMedCrossRefGoogle Scholar
  32. 32.
    Goldman MP, Alster TS, Weiss R (2007) A randomized trial to determine the influence of laser therapy, monopolar radiofrequency treatment, and intense pulsed light therapy administered immediately after hyaluronic acid gel implantation. Dermatol Surg 33:535–542PubMedCrossRefGoogle Scholar
  33. 33.
    Travis WD, Balogh K, Abraham JL (1985) Silicone granulomas: report of three cases and review of the literature. Hum Pathol 16:19–27PubMedCrossRefGoogle Scholar
  34. 34.
    Bauman LS, Halem ML (2003) Lip silicone granulomatous foreign body reaction treated with Aldara (imiquimod5%). Dermatol Surg 29:429–432CrossRefGoogle Scholar
  35. 35.
    Owens JM (2005) Soft tissue implants and fillers. Otolaryngol Clin North Am 38:361–369PubMedCrossRefGoogle Scholar
  36. 36.
    Lemperle G, Romano JJ (2003) Soft tissue augmen­tation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 29:573–587PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  1. 1.Section of Cutaneous and Aesthetic Surgery, Department of DermatologyNorthwestern UniversityChicagoUSA
  2. 2.Department of OtolaryngologyNorthwestern UniversityChicagoUSA
  3. 3.Department of SurgeryNorthwestern UniversityChicagoUSA
  4. 4.Division of DermatologyUniversity of Toronto, Women’s College HospitalTorontoCanada

Personalised recommendations